Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Nov;15(10):1547-57.
doi: 10.1017/S1461145711001982. Epub 2012 Jan 25.

Ethics and neuropsychiatric genetics: a review of major issues

Affiliations
Review

Ethics and neuropsychiatric genetics: a review of major issues

Steven K Hoge et al. Int J Neuropsychopharmacol. 2012 Nov.

Abstract

Advances in neuropsychiatric genetics hold great hopes for improved prevention, diagnosis and treatment. However, the power of genetic testing to identify individuals at increased risk for disorders and to convey information about relatives creates a set of complex ethical issues. Public attitudes are inevitably affected by the shadow of eugenics, with its history of distorting scientific findings to serve socio-political ends. Nonetheless, the growing availability of genetic tests means that more patients will seek genetic information and physicians must manage the process of informed consent to allow meaningful decisions. Patients should be helped to understand the often-limited predictive power of current knowledge, potential psychological impact, risks of stigma and discrimination and possible implications for family members. Decisions for predictive testing of children raise additional concerns, including distortions of family dynamics and negative effects on children's self-image; testing is best deferred until adulthood unless preventive interventions exist. Pharmacogenomic testing, part of personalized medicine, may bring collateral susceptibility information for which patients should be prepared. The implications of genetic findings for families raise the question of whether physicians have duties to inform family members of implications for their health. Finally, participation in research in neuropsychiatric genetics evokes a broad range of ethical concerns, including the contentious issue of the extent to which results should be returned to individual subjects. As genetic science becomes more widely applied, the public will become more sophisticated and will be likely to demand a greater role in determining social policy on these issues.

PubMed Disclaimer

Conflict of interest statement

Statement of Interests

None

Similar articles

Cited by

References

    1. American Board of Genetic Counseling. 2011 http://www.abgc.net/ABGC/AmericanBoardofGeneticCounselors.asp.
    1. American College of Obstetricians and Gynecologists Committee on Genetics. ACOG Committee Opinion No. 469: Carrier screening for fragile X syndrome. Obstetrics and Gynecology. 2010;116:1008–10. - PubMed
    1. Appelbaum PS. Genetic discrimination in mental disorders: the impact of GINA. Psychiatric Services. 2010;61:338–340. - PubMed
    1. Arranz MJ, Kapur S. Pharmacogenetics in psychiatry: are we ready for widespread clinical use? Schizophrenia Bulletin. 2008;34:1130–1144. - PMC - PubMed
    1. Ashley EA, Gutte AJ, Wheeler MT, Chen R, et al. Clinical assessment incorporating a personal genome. The Lancet. 2010;375:1525–1535. - PMC - PubMed

Publication types

MeSH terms